Cumberland Pharmaceuticals, Inc.
| Nasdaq: CPIX
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is focused on the acquisition, development and commercialization of branded prescription products. The company's primary target markets include hospital acute care and gastroenterology. Its products include Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning, Caldolor (ibuprofen) Injection, the first injectable treatment for pain and fever approved in the United States, and Kristalose (lactulose) for Oral Solution, a prescription laxative. Cumberland Pharmaceuticals was founded by A. J. Kazimi in 1999 and is headquartered in Nashville, TN.